Copyright Reports & Markets. All rights reserved.

Global OTC Gastrointestinal Products Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global OTC Gastrointestinal Products Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global OTC Gastrointestinal Products Consumption 2014-2024
        • 2.1.2 OTC Gastrointestinal Products Consumption CAGR by Region
      • 2.2 OTC Gastrointestinal Products Segment by Type
        • 2.2.1 H2 Receptor Antagonists
        • 2.2.2 Proton Pump Inhibitors (PPIs)
      • 2.3 OTC Gastrointestinal Products Consumption by Type
        • 2.3.1 Global OTC Gastrointestinal Products Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global OTC Gastrointestinal Products Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global OTC Gastrointestinal Products Sale Price by Type (2014-2019)
      • 2.4 OTC Gastrointestinal Products Segment by Application
        • 2.4.1 Hospital Pharmacies
        • 2.4.2 Drug Stores
        • 2.4.3 Retail Stores
        • 2.4.4 E-Commerce
      • 2.5 OTC Gastrointestinal Products Consumption by Application
        • 2.5.1 Global OTC Gastrointestinal Products Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global OTC Gastrointestinal Products Value and Market Share by Application (2014-2019)
        • 2.5.3 Global OTC Gastrointestinal Products Sale Price by Application (2014-2019)

      3 Global OTC Gastrointestinal Products by Players

      • 3.1 Global OTC Gastrointestinal Products Sales Market Share by Players
        • 3.1.1 Global OTC Gastrointestinal Products Sales by Players (2017-2019)
        • 3.1.2 Global OTC Gastrointestinal Products Sales Market Share by Players (2017-2019)
      • 3.2 Global OTC Gastrointestinal Products Revenue Market Share by Players
        • 3.2.1 Global OTC Gastrointestinal Products Revenue by Players (2017-2019)
        • 3.2.2 Global OTC Gastrointestinal Products Revenue Market Share by Players (2017-2019)
      • 3.3 Global OTC Gastrointestinal Products Sale Price by Players
      • 3.4 Global OTC Gastrointestinal Products Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global OTC Gastrointestinal Products Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players OTC Gastrointestinal Products Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 OTC Gastrointestinal Products by Regions

      • 4.1 OTC Gastrointestinal Products by Regions
        • 4.1.1 Global OTC Gastrointestinal Products Consumption by Regions
        • 4.1.2 Global OTC Gastrointestinal Products Value by Regions
      • 4.2 Americas OTC Gastrointestinal Products Consumption Growth
      • 4.3 APAC OTC Gastrointestinal Products Consumption Growth
      • 4.4 Europe OTC Gastrointestinal Products Consumption Growth
      • 4.5 Middle East & Africa OTC Gastrointestinal Products Consumption Growth

      5 Americas

      • 5.1 Americas OTC Gastrointestinal Products Consumption by Countries
        • 5.1.1 Americas OTC Gastrointestinal Products Consumption by Countries (2014-2019)
        • 5.1.2 Americas OTC Gastrointestinal Products Value by Countries (2014-2019)
      • 5.2 Americas OTC Gastrointestinal Products Consumption by Type
      • 5.3 Americas OTC Gastrointestinal Products Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC OTC Gastrointestinal Products Consumption by Countries
        • 6.1.1 APAC OTC Gastrointestinal Products Consumption by Countries (2014-2019)
        • 6.1.2 APAC OTC Gastrointestinal Products Value by Countries (2014-2019)
      • 6.2 APAC OTC Gastrointestinal Products Consumption by Type
      • 6.3 APAC OTC Gastrointestinal Products Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe OTC Gastrointestinal Products by Countries
        • 7.1.1 Europe OTC Gastrointestinal Products Consumption by Countries (2014-2019)
        • 7.1.2 Europe OTC Gastrointestinal Products Value by Countries (2014-2019)
      • 7.2 Europe OTC Gastrointestinal Products Consumption by Type
      • 7.3 Europe OTC Gastrointestinal Products Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa OTC Gastrointestinal Products by Countries
        • 8.1.1 Middle East & Africa OTC Gastrointestinal Products Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa OTC Gastrointestinal Products Value by Countries (2014-2019)
      • 8.2 Middle East & Africa OTC Gastrointestinal Products Consumption by Type
      • 8.3 Middle East & Africa OTC Gastrointestinal Products Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 OTC Gastrointestinal Products Distributors
      • 10.3 OTC Gastrointestinal Products Customer

      11 Global OTC Gastrointestinal Products Market Forecast

      • 11.1 Global OTC Gastrointestinal Products Consumption Forecast (2019-2024)
      • 11.2 Global OTC Gastrointestinal Products Forecast by Regions
        • 11.2.1 Global OTC Gastrointestinal Products Forecast by Regions (2019-2024)
        • 11.2.2 Global OTC Gastrointestinal Products Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global OTC Gastrointestinal Products Forecast by Type
      • 11.8 Global OTC Gastrointestinal Products Forecast by Application

      12 Key Players Analysis

      • 12.1 GlaxoSmithKline
        • 12.1.1 Company Details
        • 12.1.2 OTC Gastrointestinal Products Product Offered
        • 12.1.3 GlaxoSmithKline OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 GlaxoSmithKline News
      • 12.2 Merck
        • 12.2.1 Company Details
        • 12.2.2 OTC Gastrointestinal Products Product Offered
        • 12.2.3 Merck OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Merck News
      • 12.3 Novartis
        • 12.3.1 Company Details
        • 12.3.2 OTC Gastrointestinal Products Product Offered
        • 12.3.3 Novartis OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Novartis News
      • 12.4 Bayer
        • 12.4.1 Company Details
        • 12.4.2 OTC Gastrointestinal Products Product Offered
        • 12.4.3 Bayer OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Bayer News
      • 12.5 Pfizer
        • 12.5.1 Company Details
        • 12.5.2 OTC Gastrointestinal Products Product Offered
        • 12.5.3 Pfizer OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Pfizer News
      • 12.6 Bristol-Myers Squibb
        • 12.6.1 Company Details
        • 12.6.2 OTC Gastrointestinal Products Product Offered
        • 12.6.3 Bristol-Myers Squibb OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Bristol-Myers Squibb News

      ...

        13 Research Findings and Conclusion

        OTC gastrointestinal agents include many different classes of drugs that are used to treat gastrointestinal disorders.

        According to this study, over the next five years the OTC Gastrointestinal Products market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in OTC Gastrointestinal Products business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares, and growth opportunities of OTC Gastrointestinal Products market by product type, application, key manufacturers and key regions and countries.

        This study considers the OTC Gastrointestinal Products value and volume generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
        H2 Receptor Antagonists
        Proton Pump Inhibitors (PPIs)
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
        Hospital Pharmacies
        Drug Stores
        Retail Stores
        E-Commerce

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        GlaxoSmithKline
        Merck
        Novartis
        Bayer
        Pfizer
        Bristol-Myers Squibb
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global OTC Gastrointestinal Products consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of OTC Gastrointestinal Products market by identifying its various subsegments.
        Focuses on the key global OTC Gastrointestinal Products manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the OTC Gastrointestinal Products with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the consumption of OTC Gastrointestinal Products submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now